Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Medicinal Chemistry Strategies for the Development of Inhibitors Disrupting β-Catenin’s Interactions with Its Nuclear Partners
Hao Zhang, Chenglong Liu, Di Zhu, et al.
Journal of Medicinal Chemistry (2022) Vol. 66, Iss. 1, pp. 1-31
Closed Access | Times Cited: 10

Showing 10 citing articles:

A New Wave of Targeting ‘Undruggable’ Wnt Signaling for Cancer Therapy: Challenges and Opportunities
Woo Jung Park, Moon Jong Kim
Cells (2023) Vol. 12, Iss. 8, pp. 1110-1110
Open Access | Times Cited: 29
Self-assembled PROTACs enable protein degradation to reprogram the tumor microenvironment for synergistically enhanced colorectal cancer immunotherapy
Xinchen Lu, Jinmei Jin, Ye Wu, et al.
Bioactive Materials (2024) Vol. 43, pp. 255-272
Open Access | Times Cited: 5
Discovery of a novel 2,4‐thiazolidinedione derivative as dual inhibitor of β‐catenin/TCF4 interaction and tubulin polymerization in colon cancer cells
Yating Guo, Meng Cao, Zhaohui Li, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 3
Closed Access
Acetyltransferases CBP/p300 Control Transcriptional Switch of β-Catenin and Stat1 Promoting Osteoblast Differentiation
Linlin Zhang, Ke-Cheng Zhu, Jing-zun Xu, et al.
Journal of Bone and Mineral Research (2023) Vol. 38, Iss. 12, pp. 1885-1899
Open Access | Times Cited: 10
YTHDF2 protein stabilization by the deubiquitinase OTUB1 promotes prostate cancer cell proliferation via PRSS8 mRNA degradation
Xuefeng Zhao, Suli Lv, Neng Li, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 4, pp. 107152-107152
Open Access | Times Cited: 3
Novel N-(Heterocyclylphenyl)benzensulfonamide Sharing an Unreported Binding Site with T-Cell Factor 4 at the β-Catenin Armadillo Repeats Domain as an Anticancer Agent
Marianna Nalli, Laura Di Magno, Yichao Wen, et al.
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 7, pp. 1087-1103
Open Access | Times Cited: 3
Design, Synthesis, and Evaluation of 18F-Labeling CYP1B1 PET Tracer Based on 2-Phenylquinazolin
Jiajing Cai, Lan Yi, Xia Zhu, et al.
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 96, pp. 129533-129533
Closed Access | Times Cited: 2
The Role of Acetyltransferase in Breast Cancer
Zilai Hu, Jia Li, Hu Wang, et al.
(2024)
Closed Access
Development of N-(4-(1H-Imidazol-1-yl)phenyl)-4-chlorobenzenesulfonamide, a Novel Potent Inhibitor of β-Catenin with Enhanced Antitumor Activity and Metabolic Stability
Michela Puxeddu, Lele Ling, Silvia Ripa, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 22, pp. 20298-20314
Closed Access
Design, synthesis, and biological evaluation of novel 8-substituted quercetin derivatives targeting the β‑catenin/B-cell lymphoma 9 interaction
Xinyan Peng, Lian Shen, Ya Bao, et al.
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 98, pp. 129591-129591
Closed Access | Times Cited: 1
Page 1

Scroll to top